ABT241108C115000
- 3.20
- -0.60-15.79%
Abbott Laboratories Newsroom
Tuesday Market Closed Up, with Presidency in Sight | Wall Street Today
We Want YOU to Submit Questions for Election Night
Market Climbs for Election Day Excitement | Live Stock
Abbott Laboratories Analyst Ratings
Abbott Laboratories Insiders Sell US$3.0m Of Stock, Possibly Signalling Caution
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $149
Monday Market Moves Sideways, Election and FOMC in Sight | Wall Street Today
Express News | Abbott -Late-Breaking Data Shows Sustained Benefits of Abbott's Esprit Btk System for People Battling Peripheral Artery Disease Below the Knee
Monday Market Mixed Before Crazy, Pivotal Week | Live Stock
Abbott Laboratories' (NYSE:ABT) Share Price Not Quite Adding Up
Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $149
Barclays Adjusts Abbott Laboratories Price Target to $149 From $143
Late-Breaking Data Shows Sustained Benefits of Abbott's Esprit BTK System for People Battling Peripheral Artery Disease Below the Knee
Top Gap Ups and Downs on Friday: AMZN, ABT, TEAM and More
Weekly Buzz: Magnificent Mix of Market Reactions
November Starts with a Climb to end Tough Week | Wall Street Today
Stocks That Hedge Funds Moved From Long to Short in August - Jefferies
Lysol's surge boosts European stock markets as traders digest US employment data.
European stock markets rose on Friday, ending a three-day decline. Reckitt Benckiser achieved its largest increase in 24 years. The increase in US non-farm payrolls was below expectations, causing investors to weigh the outlook for the US economy. At the close in London, the STOXX Europe 600 index rose by 1.1%. Reckitt Benckiser's stock price surged by 12% at one point, marking the largest increase since March 2000, as a US jury ruled the company and Abbott Laboratories innocent in a lawsuit accusing them of concealing potential risks of premature infant formula. This also boosted the personal care sector. European stock markets saw the biggest monthly drop in a year in October, with a series of weak corporate earnings reports sparking concerns about the economy.
Express News | Abbott Laboratories Shares Are Trading Higher After the Company Announced It Along With Reckitt Benckiser Won Its First Trial in Premature-infant Formula Litigation and Is Cleared of Allegations of Hiding Bowel Disease Risks
U.S. stock market anomaly | abbott laboratories (ABT.US) rises more than 5%, marking the largest intraday gain since April last year.
On Friday, abbott laboratories (ABT.US) opened strong, achieving the largest intraday increase since April 2023, with a gain of over 5% as of the time of writing, trading at $119.61.